These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

687 related items for PubMed ID: 18055978

  • 1. Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease.
    Noizat-Pirenne F, Bachir D, Chadebech P, Michel M, Plonquet A, Lecron JC, Galactéros F, Bierling P.
    Haematologica; 2007 Dec; 92(12):e132-5. PubMed ID: 18055978
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical significance of serologic markers related to red blood cell autoantibodies production after red blood cell transfusion-severe autoimmune hemolytic anemia occurring after transfusion and alloimmunization: successful treatment with rituximab.
    Sigler E, Shvidel L, Yahalom V, Berrebi A, Shtalrid M.
    Transfusion; 2009 Jul; 49(7):1370-4. PubMed ID: 19374728
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Anti-s antibody-associated delayed hemolytic transfusion reaction in patients with sickle cell anemia.
    Kalyanaraman M, Heidemann SM, Sarnaik AP, Meert KL, Sarnaik SA.
    J Pediatr Hematol Oncol; 1999 Jul; 21(1):70-3. PubMed ID: 10029818
    [Abstract] [Full Text] [Related]

  • 8. Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion.
    Uhlmann EJ, Shenoy S, Goodnough LT.
    Transfusion; 2014 Feb; 54(2):384-8. PubMed ID: 23692505
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Delayed hemolytic transfusion reaction with hyperhemolysis after first red blood cell transfusion in child with beta-thalassemia: challenges in treatment.
    Hannema SE, Brand A, van Meurs A, Smiers FJ.
    Transfusion; 2010 Feb; 50(2):429-32. PubMed ID: 19788508
    [Abstract] [Full Text] [Related]

  • 11. Cerebrovascular accident during a delayed hemolytic transfusion reaction in a patient with sickle cell anemia.
    Mintz PD, Williams ME.
    Ann Clin Lab Sci; 1986 Feb; 16(3):214-8. PubMed ID: 3717883
    [Abstract] [Full Text] [Related]

  • 12. Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells.
    King KE, Shirey RS, Lankiewicz MW, Young-Ramsaran J, Ness PM.
    Transfusion; 1997 Apr; 37(4):376-81. PubMed ID: 9111274
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Red cell exchange does not appear to increase the rate of allo- and auto-immunization in chronically transfused children with sickle cell disease.
    Venkateswaran L, Teruya J, Bustillos C, Mahoney D, Mueller BU.
    Pediatr Blood Cancer; 2011 Aug; 57(2):294-6. PubMed ID: 21298771
    [Abstract] [Full Text] [Related]

  • 18. Management of delayed hemolytic transfusion reaction in sickle cell disease: Prevention, diagnosis, treatment.
    Pirenne F, Bartolucci P, Habibi A.
    Transfus Clin Biol; 2017 Sep; 24(3):227-231. PubMed ID: 28669521
    [Abstract] [Full Text] [Related]

  • 19. Relevance of blood groups in transfusion of sickle cell disease patients.
    Noizat-Pirenne F.
    C R Biol; 2013 Mar; 336(3):152-8. PubMed ID: 23643398
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.